Metabolic cardioprotector therapy in pediatric sports medicine
Our previous studies have demonstrated the importance of early diagnostics and treatment of pathological cardiac transformations in young athletes. The present pilot clinical study is focused on cardioprotective effects of 2-ethyl-6-methyl-3-oxypyridine succinate (Mexicor, EcoPharmInvest) in young athletes with stress cardiomyopathy. It was demonstrated that Mexicor is at least as effective as creatine phosphate, a gold standard medication in sports medicine, for correction of hemodynamic, autonomic, or metabolic disturbances, as well as exercise capacity improvement. The results obtained enable us to increase the range of metabolic medications used in sports cardiology